Cargando…

Multiple Aspects of Gene Dysregulation in Huntington’s Disease

Huntington’s Disease (HD) is a genetic neurodegenerative disease caused by a CAG expansion in the gene encoding Huntingtin (Htt). It is characterized by chorea, cognitive, and psychiatric disorders. The most affected brain region is the striatum, and the clinical symptoms are directly correlated to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moumné, Lara, Betuing, Sandrine, Caboche, Jocelyne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806340/ https://www.ncbi.nlm.nih.gov/pubmed/24167500 http://dx.doi.org/10.3389/fneur.2013.00127

Ejemplares similares

Altered Cholesterol Homeostasis in Huntington’s Disease
por: Kacher, Radhia, et al.
Publicado: (2022)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
por: Boussicault, Lydie, et al.
Publicado: (2016)

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter
por: Martin, Elodie, et al.
Publicado: (2011)

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease
por: Nóbrega, Clévio, et al.
Publicado: (2020)

Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease
por: Miller, Benjamin R., et al.
Publicado: (2011)

Elk-1 a Transcription Factor with Multiple Facets in the Brain
por: Besnard, Antoine, et al.
Publicado: (2011)

Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation
por: Deyts, Carole, et al.
Publicado: (2009)

Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum
por: Pinchaud, Katleen, et al.
Publicado: (2023)

Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease
por: Moumné, Lara, et al.
Publicado: (2012)

Editorial: Cholesterol and Neurodegenerative Diseases - Pressing Questions and How to Address Them
por: Betuing, Sandrine, et al.
Publicado: (2022)

Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington’s Disease
por: Serranilla, Melissa, et al.
Publicado: (2022)

Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
por: Pla, Patrick, et al.
Publicado: (2014)

Corrigendum: Striatal Chloride Dysregulation and Impaired GABAergic Signaling Due to Cation-Chloride Cotransporter Dysfunction in Huntington's Disease
por: Serranilla, Melissa, et al.
Publicado: (2022)

Disrupting D1-NMDA or D2-NMDA receptor heteromerization prevents cocaine’s rewarding effects but preserves natural reward processing
por: Andrianarivelo, Andry, et al.
Publicado: (2021)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Acanthocytes Identified in Huntington’s Disease
por: Yu, Yueyi, et al.
Publicado: (2022)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Commentary: Acanthocytes identified in Huntington's disease
por: Peikert, Kevin, et al.
Publicado: (2022)

Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease
por: Czeredys, Magdalena, et al.
Publicado: (2013)

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
por: Dickson, Elna, et al.
Publicado: (2022)

Phosphoproteomic dysregulation in Huntington’s disease mice is rescued by environmental enrichment
por: Mees, Isaline, et al.
Publicado: (2022)

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
por: Mees, Isaline, et al.
Publicado: (2023)

Role of cerebral cortex in the neuropathology of Huntington's disease
por: Estrada-Sánchez, Ana M., et al.
Publicado: (2013)

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Ubiquitin–proteasome system involvement in Huntington’s disease
por: Ortega, Zaira, et al.
Publicado: (2014)

Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease
por: Highet, Blake, et al.
Publicado: (2020)

Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
por: Wiprich, Melissa Talita, et al.
Publicado: (2021)

Pain in Huntington’s disease and its potential mechanisms
por: Li, Jiajie, et al.
Publicado: (2023)

Huntington's disease: of mice and men
por: Yhnel, Emma
Publicado: (2017)

A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington’s Disease Gene Mutation
por: Du, Xin, et al.
Publicado: (2013)

Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington’s Disease
por: Podvin, Sonia, et al.
Publicado: (2022)

Refining the diagnosis of Huntington disease: the PREDICT-HD study
por: Biglan, Kevin M., et al.
Publicado: (2013)

Risk-taking and pathological gambling behavior in Huntington’s disease
por: Kalkhoven, Carla, et al.
Publicado: (2014)

Proteostasis in striatal cells and selective neurodegeneration in Huntington’s disease
por: Margulis, Julia, et al.
Publicado: (2014)

Molecular Imaging Markers to Track Huntington’s Disease Pathology
por: Wilson, Heather, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qk37o4rsb2vt6gaq53bq6qvns0